Gender difference of association between LDL cholesterol concentrations and mortality from coronary heart disease amongst Japanese: The Ibaraki Prefectural Health Study

Journal of Internal Medicine

Volumn 267, Issue 6, 2010, Pages 576-587

  Noda, H ^a,b   Iso, H ^a   Irie, F ^c   Sairenchi, T ^d,e   Ohtaka, E ^e   Ohta, H ^e  

^a OSAKA UNIVERSITY   (Japan)

^b HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

^c Ibaraki Prefectural Office   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e Ibaraki Health Service Association   (Japan)

Author keywords

Coronary heart disease; Gender; LDL

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS;

EID: 77951918858     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02183.x     Document Type: Article

References (31)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 3421.
2. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004 24 : e149 61.
3. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006 98 : 1363 1368. (Pubitemid 44666646)
4. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006 48 : 2235 2242. (Pubitemid 44855447)
5. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 2007 48 : 2499 2505.
6. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003 326 : 1423.
7. Verschuren WM, Jacobs DR, Bloemberg BP et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995 274 : 131 136.
8. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992 24 : 465 468. (Pubitemid 23014471)
9. Vasan RS, Sullivan LM, Wilson PW et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 2005 142 : 393 402.
10. Kromhout D, Bloemberg B, Seidell JC, Nissinen A, Menotti A. Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study. Int J Obes Relat Metab Disord 2001 25 : 301 306. (Pubitemid 32209803)
11. Irie F, Sairenchi T, Iso H, Shimamoto T. Prediction of mortality from findings of annual health checkups utility for health care programs. Nippon Koshu Eisei Zasshi 2001 48 : 95 108.
12. Noda H, Iso H, Sairenchi T et al. Prediction of stroke, coronary heart disease, cardiovascular disease, cancer, and total death based on results of annual health checkups. Nippon Koshu Eisei Zasshi 2006 53 : 265 276.
13. Irie F, Iso H, Sairenchi T et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006 69 : 1264 1271.
14. The Council for International Organizations of Medical Sciences (COIMS). International guidelines for ethical review of epidemiological studies. Law Med Health Care 1991 19 : 247 258.
15. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003 10 : 145 153.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
17. Tremblay AJ, Morrissette H, Gagne JM, Bergeron J, Gagne C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004 37 : 785 790. (Pubitemid 39141120)
18. Ng'andu NH. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model. Stat Med 1997 16 : 611 626.
19. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999 94 : 496 509.
20. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989 8 : 551 561. (Pubitemid 19116001)
21. Sacks FM, Tonkin AM, Shepherd J et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000 102 : 1893 1900.
22. Okamura T, Kokubo Y, Watanabe M et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study. Atherosclerosis 2009 203 : 587 592.
23. Imamura T, Doi Y, Arima H et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009 40 : 382 388.
24. Okumiya N, Tanaka K, Ueda K, Omae T. Coronary atherosclerosis and antecedent risk factors: pathologic and epidemiologic study in Hisayama, Japan. Am J Cardiol 1985 56 : 62 6. (Pubitemid 15069288)
25. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987 114 : 413 419. (Pubitemid 17131737)
26. O'Keefe JH Jr., Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004 43 : 2142 2146. (Pubitemid 38686815)
27. Jacobs D, Blackburn H, Higgins M et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992 86 : 1046 1060.
28. Noda H, Iso H, Irie F et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 2009 119 : 2136 2145.
29. Iso H, Date C, Yamamoto A et al. Perceived mental stress and mortality from cardiovascular disease among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study). Circulation 2002 106 : 1229 1236. (Pubitemid 34988641)
30. Ikeda A, Iso H, Toyoshima H et al. Marital status and mortality among Japanese men and women: the Japan Collaborative Cohort Study. BMC Public Health 2007 7 : 73. (Pubitemid 46788697)
31. Ikeda A, Iso H, Kawachi I, Inoue M, Tsugane S JPHC Study Group. Type A behaviour and risk of coronary heart disease: the JPHC Study. Int J Epidemiol 2008 37 : 1395 1405. (Pubitemid 351619562)